NorthWest Biotherapeutics Inc (NWBO)

[skitahoe]

I agree, it won't happen on just the UK alone, but I believe that once we have approval of the EDEN, approvals by other regulators won't take that long.

We all know the benefits of combining with Poly-ICLC and other therapeutics, we don't need approvals in other trials for that to happen off label for most patients. I once said it would be medical malpractice if it didn't happen.

I believe that much the same applies to its use in other cancers. Trials proving it's benefits in other cancers will take several years for label approval, but again that doesn't mean it can't be used off label.

I don't know if the full records for compassionate use in the UK will ever be released, but I believe sufficient anecdotal evidence is know about patients with other cancers that it will be used once there is adequate supply, meaning the EDEN units are being mass produced to meet demands.

I can't say what trials will be run, or when they'll be run, but word will get out if benefits are being seen in cancers like pancreatic, lung, breast, etc. and that, along with existing anecdotal evidence will be all that's needed to force insurance to pay for the vaccine well before actual approval is achieved.

If I'm right about this, in three to five years from now DCVax-L will be one of the biggest earning products on the market.

Gary